Accession Number: | 0001209191-21-038696 |
Date: | 2021-06-04 |
Issuer: | NEOLEUKIN THERAPEUTICS, INC. (NLTX) |
Original Submission Date: |
WALKEY CARL
CO NEOLEUKIN THERAPEUTICS, INC.
188 EAST BLAINE STREET, #450
SEATTLE, WA 98102
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-04 | S | 600 | d | $10.00 | 1,354,339 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | this transaction was effected pursuant to a rule 10b5-1 trading plan previously adopted by the reporting person. |